Rennova Health, Inc.
RNVA
$0.00
$0.000.00%
09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
---|---|---|---|---|---|
Net Income | 1.08M | 283.90K | -219.90K | -3.29M | -5.02M |
Total Depreciation and Amortization | 268.80K | 329.40K | 446.60K | 469.30K | 481.00K |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | -1.72M | -1.26M | -1.18M | -955.80K | -316.80K |
Change in Net Operating Assets | 2.21M | 2.78M | 3.02M | 3.56M | 462.50K |
Cash from Operations | 1.84M | 2.13M | 2.07M | -218.40K | -4.39M |
Capital Expenditure | -267.40K | -221.80K | -255.70K | -35.20K | -34.80K |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -809.10K | -754.90K | -1.06M | -869.90K | -722.90K |
Cash from Investing | -1.08M | -976.70K | -1.31M | -905.30K | -757.80K |
Total Debt Issued | 1.23M | 1.07M | 1.38M | 1.55M | 900.00K |
Total Debt Repaid | -2.15M | -2.01M | -2.25M | -1.75M | -2.09M |
Issuance of Common Stock | -- | -- | -- | -- | -- |
Repurchase of Common Stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Issuance of Preferred Stock | 0.00 | 0.00 | 500.00K | 1.50M | 5.50M |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -211.80K | -86.30K | -245.10K | -403.90K | 512.50K |
Cash from Financing | -1.13M | -1.03M | -614.50K | 898.40K | 4.83M |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | -361.30K | 124.40K | 148.00K | -225.00K | -320.50K |